Published on
December 9, 2025
- 18:28 GMT
Lunai Bioworks Advances Parkinson’s Subtype Targets Toward Preclinical Validation
Company advances subtype-linked targets into validation, supporting faster proof-of-concept and strategic partnering discussions Lunai Bioworks (NASDAQ:LNAI) SACRAMENTO, FL, UNITED STATES, December 9, 2025 /EINPresswire.com/ -- Lunai Bioworks (NASDAQ: …
Distribution channels:
Banking, Finance & Investment Industry, Business & Economy
...
